Difference between revisions of "Team:GreatBay SCIE/Notebook"
| Line 45: | Line 45: | ||
<li><a href="https://2021.igem.org/Team:GreatBay_SCIE/Design">Design</a></li> | <li><a href="https://2021.igem.org/Team:GreatBay_SCIE/Design">Design</a></li> | ||
| − | <li><a href="https://2021.igem.org/Team:GreatBay_SCIE/Proof_Of_Concept">Proof of Concept</a></li> | + | <li><a href="https://2021.igem.org/Team:GreatBay_SCIE/Proof_Of_Concept">Proof of Concept</a></li> |
<li><a href="https://2021.igem.org/Team:GreatBay_SCIE/Results">Results</a></li> | <li><a href="https://2021.igem.org/Team:GreatBay_SCIE/Results">Results</a></li> | ||
<li><a href="https://2021.igem.org/Team:GreatBay_SCIE/Engineering">Engineering</a></li> | <li><a href="https://2021.igem.org/Team:GreatBay_SCIE/Engineering">Engineering</a></li> | ||
| Line 57: | Line 57: | ||
<ul> | <ul> | ||
<li><a href="https://2021.igem.org/Team:GreatBay_SCIE/Experiments">Experimental Design</a></li> | <li><a href="https://2021.igem.org/Team:GreatBay_SCIE/Experiments">Experimental Design</a></li> | ||
| − | <li><a href="https://2021.igem.org/Team:GreatBay_SCIE/Safety">Safety</a></li> | + | <li><a href="https://2021.igem.org/Team:GreatBay_SCIE/Results">Results</a></li> |
| − | + | <li><a href="https://2021.igem.org/Team:GreatBay_SCIE/Safety">Safety</a></li> | |
<li><a href="https://2021.igem.org/Team:GreatBay_SCIE/Notebook">Lab Notes</a></li> | <li><a href="https://2021.igem.org/Team:GreatBay_SCIE/Notebook">Lab Notes</a></li> | ||
<li><a href="https://2021.igem.org/Team:GreatBay_SCIE/Protocol">Protocol</a></li> | <li><a href="https://2021.igem.org/Team:GreatBay_SCIE/Protocol">Protocol</a></li> | ||
| Line 71: | Line 71: | ||
<li><a href="https://2021.igem.org/Team:GreatBay_SCIE/Optimum_Aptamer_Concentration" >Optimum Liposome-Aptamer Ratio</a></li> | <li><a href="https://2021.igem.org/Team:GreatBay_SCIE/Optimum_Aptamer_Concentration" >Optimum Liposome-Aptamer Ratio</a></li> | ||
<li><a href="https://2021.igem.org/Team:GreatBay_SCIE/Drug_Loading">Drug Loading</a></li> | <li><a href="https://2021.igem.org/Team:GreatBay_SCIE/Drug_Loading">Drug Loading</a></li> | ||
| − | <li><a href="https://2021.igem.org/Team:GreatBay_SCIE/3D_Model">3D Models</a></li> | + | <li><a href="https://2021.igem.org/Team:GreatBay_SCIE/Dissociation_constant">Dissociation_constant</a></li> |
| + | <li><a href="https://2021.igem.org/Team:GreatBay_SCIE/3D_Model">3D Models</a></li> | ||
</ul> | </ul> | ||
| Line 78: | Line 79: | ||
<a href="https://2021.igem.org/Team:GreatBay_SCIE/Human_Practices">Human Practices</a> | <a href="https://2021.igem.org/Team:GreatBay_SCIE/Human_Practices">Human Practices</a> | ||
<ul> | <ul> | ||
| + | <li><a href="https://2021.igem.org/Team:GreatBay_SCIE/Human_Practices">Integrated Human Practices</a></li> | ||
<li><a href="https://2021.igem.org/Team:GreatBay_SCIE/Communication">Public Engagement & Education</a></li> | <li><a href="https://2021.igem.org/Team:GreatBay_SCIE/Communication">Public Engagement & Education</a></li> | ||
| − | <li><a href="https://2021.igem.org/Team:GreatBay_SCIE/ | + | <li><a href="https://2021.igem.org/Team:GreatBay_SCIE/BreastCancerInChina">GreatBay_SCIE X Pink Ribbon</a></li> |
<li><a href="https://2021.igem.org/Team:GreatBay_SCIE/Collaborations">Collaborations</a></li> | <li><a href="https://2021.igem.org/Team:GreatBay_SCIE/Collaborations">Collaborations</a></li> | ||
| − | <li><a href="https://2021.igem.org/Team:GreatBay_SCIE/ | + | <li><a href="https://2021.igem.org/Team:GreatBay_SCIE/Partnership">Partnership with SMS_Shenzhen</a></li> |
</ul> | </ul> | ||
</li> | </li> | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
</ul> | </ul> | ||
</div> | </div> | ||
Revision as of 01:52, 21 October 2021
Lab Notebook
Aptamer Lab Note
ELONA
(Scroll down to see more in the pdf below)
All raw data for aptamer lab are compiled here